Autobioluminescence outperforms endpoint assays. NIH/NCATS validates 490 BioTech’s HEK293 cell line as a high-throughput drug discovery tool.
Making waves in Biotech. 490 BioTech has been recognized as one of the top 5 Highly Promising Companies of 2018 by the Pepperdine Graziadio school of business.
Easier for technicians and less painful for subjects. NC3Rs recognizes autobioluminescence as a preferred method for improving animal welfare by removing the need for repeated luciferin injections.
Putting innovation to work. The introduction of autobioluminescent technology to the marketplace in 2013 was recognized as one of the top 10 most innovative new products of the year.